| Dr Neil Senior, MD | |
|
80 Linden St, Brattleboro, VT 05301-2965 | |
| (802) 254-2291 | |
| Not Available |
| Full Name | Dr Neil Senior |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 54 Years |
| Location | 80 Linden St, Brattleboro, Vermont |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588698252 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 0420006149 (Vermont) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Community Health Centers Of The Rutland Region Inc | 2961467386 | 85 |
News Archive
New research suggests that just one dose of the anesthetic ketamine appears to reduce depression in patients who show little improvement with standard medications.
Researchers in Newcastle and Singapore have identified a new type of white blood cell which activates a killing immune response to an external source - providing a new potential target for vaccines for conditions such as cancer or Hepatitis B.
Questcor Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved Questcor's supplemental new drug application (sNDA) for H.P. Acthar® Gel (repository corticotropin injection) in the treatment of infantile spasms (IS), an ultra-rare orphan disorder affecting approximately 2,000 American children annually. IS is a devastating and potentially life-threatening form of epilepsy seen in infancy and early childhood.
Humiliation in physical education class as a child can turn people off fitness for good, according to a University of Alberta researcher.
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
› Verified 2 days ago
| Entity Name | Matrix Health Systems Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104872712 PECOS PAC ID: 1052219359 Enrollment ID: O20031230000156 |
News Archive
New research suggests that just one dose of the anesthetic ketamine appears to reduce depression in patients who show little improvement with standard medications.
Researchers in Newcastle and Singapore have identified a new type of white blood cell which activates a killing immune response to an external source - providing a new potential target for vaccines for conditions such as cancer or Hepatitis B.
Questcor Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved Questcor's supplemental new drug application (sNDA) for H.P. Acthar® Gel (repository corticotropin injection) in the treatment of infantile spasms (IS), an ultra-rare orphan disorder affecting approximately 2,000 American children annually. IS is a devastating and potentially life-threatening form of epilepsy seen in infancy and early childhood.
Humiliation in physical education class as a child can turn people off fitness for good, according to a University of Alberta researcher.
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
› Verified 2 days ago
| Entity Name | Rutland Mental Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164417283 PECOS PAC ID: 6709850324 Enrollment ID: O20040820000343 |
News Archive
New research suggests that just one dose of the anesthetic ketamine appears to reduce depression in patients who show little improvement with standard medications.
Researchers in Newcastle and Singapore have identified a new type of white blood cell which activates a killing immune response to an external source - providing a new potential target for vaccines for conditions such as cancer or Hepatitis B.
Questcor Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved Questcor's supplemental new drug application (sNDA) for H.P. Acthar® Gel (repository corticotropin injection) in the treatment of infantile spasms (IS), an ultra-rare orphan disorder affecting approximately 2,000 American children annually. IS is a devastating and potentially life-threatening form of epilepsy seen in infancy and early childhood.
Humiliation in physical education class as a child can turn people off fitness for good, according to a University of Alberta researcher.
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
› Verified 2 days ago
| Entity Name | Community Health Centers Of The Rutland Region Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336193838 PECOS PAC ID: 2961467386 Enrollment ID: O20041129000357 |
News Archive
New research suggests that just one dose of the anesthetic ketamine appears to reduce depression in patients who show little improvement with standard medications.
Researchers in Newcastle and Singapore have identified a new type of white blood cell which activates a killing immune response to an external source - providing a new potential target for vaccines for conditions such as cancer or Hepatitis B.
Questcor Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved Questcor's supplemental new drug application (sNDA) for H.P. Acthar® Gel (repository corticotropin injection) in the treatment of infantile spasms (IS), an ultra-rare orphan disorder affecting approximately 2,000 American children annually. IS is a devastating and potentially life-threatening form of epilepsy seen in infancy and early childhood.
Humiliation in physical education class as a child can turn people off fitness for good, according to a University of Alberta researcher.
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
› Verified 2 days ago
| Entity Name | Community Health Centers Of The Rutland Region Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073567590 PECOS PAC ID: 2961467386 Enrollment ID: O20041129000784 |
News Archive
New research suggests that just one dose of the anesthetic ketamine appears to reduce depression in patients who show little improvement with standard medications.
Researchers in Newcastle and Singapore have identified a new type of white blood cell which activates a killing immune response to an external source - providing a new potential target for vaccines for conditions such as cancer or Hepatitis B.
Questcor Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved Questcor's supplemental new drug application (sNDA) for H.P. Acthar® Gel (repository corticotropin injection) in the treatment of infantile spasms (IS), an ultra-rare orphan disorder affecting approximately 2,000 American children annually. IS is a devastating and potentially life-threatening form of epilepsy seen in infancy and early childhood.
Humiliation in physical education class as a child can turn people off fitness for good, according to a University of Alberta researcher.
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
› Verified 2 days ago
| Entity Name | Community Health Centers Of The Rutland Region Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104870922 PECOS PAC ID: 2961467386 Enrollment ID: O20050131001023 |
News Archive
New research suggests that just one dose of the anesthetic ketamine appears to reduce depression in patients who show little improvement with standard medications.
Researchers in Newcastle and Singapore have identified a new type of white blood cell which activates a killing immune response to an external source - providing a new potential target for vaccines for conditions such as cancer or Hepatitis B.
Questcor Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved Questcor's supplemental new drug application (sNDA) for H.P. Acthar® Gel (repository corticotropin injection) in the treatment of infantile spasms (IS), an ultra-rare orphan disorder affecting approximately 2,000 American children annually. IS is a devastating and potentially life-threatening form of epilepsy seen in infancy and early childhood.
Humiliation in physical education class as a child can turn people off fitness for good, according to a University of Alberta researcher.
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
› Verified 2 days ago
| Entity Name | Community Health Centers Of The Rutland Region Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467681114 PECOS PAC ID: 2961467386 Enrollment ID: O20100804000784 |
News Archive
New research suggests that just one dose of the anesthetic ketamine appears to reduce depression in patients who show little improvement with standard medications.
Researchers in Newcastle and Singapore have identified a new type of white blood cell which activates a killing immune response to an external source - providing a new potential target for vaccines for conditions such as cancer or Hepatitis B.
Questcor Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved Questcor's supplemental new drug application (sNDA) for H.P. Acthar® Gel (repository corticotropin injection) in the treatment of infantile spasms (IS), an ultra-rare orphan disorder affecting approximately 2,000 American children annually. IS is a devastating and potentially life-threatening form of epilepsy seen in infancy and early childhood.
Humiliation in physical education class as a child can turn people off fitness for good, according to a University of Alberta researcher.
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
› Verified 2 days ago
| Entity Name | Community Health Centers Of The Rutland Region Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780969345 PECOS PAC ID: 2961467386 Enrollment ID: O20120321000420 |
News Archive
New research suggests that just one dose of the anesthetic ketamine appears to reduce depression in patients who show little improvement with standard medications.
Researchers in Newcastle and Singapore have identified a new type of white blood cell which activates a killing immune response to an external source - providing a new potential target for vaccines for conditions such as cancer or Hepatitis B.
Questcor Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved Questcor's supplemental new drug application (sNDA) for H.P. Acthar® Gel (repository corticotropin injection) in the treatment of infantile spasms (IS), an ultra-rare orphan disorder affecting approximately 2,000 American children annually. IS is a devastating and potentially life-threatening form of epilepsy seen in infancy and early childhood.
Humiliation in physical education class as a child can turn people off fitness for good, according to a University of Alberta researcher.
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Neil Senior, MD 80 Linden St, Brattleboro, VT 05301-2965 Ph: (802) 254-2291 | Dr Neil Senior, MD 80 Linden St, Brattleboro, VT 05301-2965 Ph: (802) 254-2291 |
News Archive
New research suggests that just one dose of the anesthetic ketamine appears to reduce depression in patients who show little improvement with standard medications.
Researchers in Newcastle and Singapore have identified a new type of white blood cell which activates a killing immune response to an external source - providing a new potential target for vaccines for conditions such as cancer or Hepatitis B.
Questcor Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved Questcor's supplemental new drug application (sNDA) for H.P. Acthar® Gel (repository corticotropin injection) in the treatment of infantile spasms (IS), an ultra-rare orphan disorder affecting approximately 2,000 American children annually. IS is a devastating and potentially life-threatening form of epilepsy seen in infancy and early childhood.
Humiliation in physical education class as a child can turn people off fitness for good, according to a University of Alberta researcher.
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
› Verified 2 days ago
Dr. Saba Salam, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 830 Western Ave, Brattleboro, VT 05301 Phone: 802-246-0781 Fax: 802-246-0742 | |
Timothy Larosa, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1 Anna Marsh Lane, Brattleboro, VT 05302 Phone: 802-258-3707 Fax: 802-258-3788 | |
Dorothea L. De Gutis, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 51 Fairview St, Brattleboro, VT 05301 Phone: 802-254-6028 Fax: 802-254-7501 | |
Dr. Lance Budge Thigpen, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1 Anna Marsh Lane, Brattleboro, VT 05302 Phone: 802-258-7785 Fax: 802-258-3723 | |
Dr. Milangel Thaymee Concepcion Zayas, MD, MPH Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1 Anna Marsh Lane, Brattleboro Retreat- Anna Marsh Behavioral Care Clinic, Brattleboro, VT 05302 Phone: 802-257-7785 | |
Elizabeth H Joseph, D.O. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: Anna Marsh Lane, Brattleboro Retreat, Brattleboro, VT 05302 Phone: 802-258-4354 | |
Stuart A. Copans, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 51 Fairview St., Hcrs, Brattleboro, VT 05301 Phone: 802-254-6028 |